Discontinued — last reported Q4 '25
MicroStrategy Interest Paid remained flat by 0.0% to $11.63M in Q2 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $11.14M to $11.63M. Over 5 years (FY 2021 to FY 2026), Interest Paid shows an upward trend with a 204.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | FY'26 | |
|---|---|---|---|---|---|---|
| Value | $178.00K | $20.42M | $43.45M | $41.23M | $44.57M | $46.53M |
| YoY Change | — | >999% | +112.8% | -5.1% | +8.1% | +4.4% |